FranΓ§aisπ See the interactive version (live chart) β
| Investment | Value today | Gain |
|---|---|---|
| 1 years ago (2025) | $1,416 | +42% |
| 3 years ago (2023) | $1,557 | +56% |
| 5 years ago (2021) | $2,348 | +135% |
| 10 years ago (2016) | $4,248 | +325% |
| since 2013 | $6,816 | +582% |
| Year | Year's return | $1,000 invested at year start β worth today |
|---|---|---|
| 2026 (YTD) | +10% | $1,101 (+10%) |
| 2025 | +29% | $1,416 (+42%) |
| 2024 | +15% | $1,624 (+62%) |
| 2023 | -4% | $1,557 (+56%) |
| 2022 | +19% | $1,858 (+86%) |
| 2021 | +26% | $2,348 (+135%) |
| 2020 | +21% | $2,842 (+184%) |
| 2019 | -4% | $2,730 (+173%) |
| 2018 | -5% | $2,602 (+160%) |
| 2017 | +54% | $4,019 (+302%) |
| 2016 | +6% | $4,248 (+325%) |
π See the analyst analysis of AbbVie β
$1000 invested in AbbVie 5 years ago would be worth $2,348 today, and $4,248 over 10 years (price return, excluding dividends).
Calendar-year returns β 2024: +15%. 2025: +29%. 2026: +10%. Full breakdown in the table above.
Over 10 years, AbbVie's average annual return (CAGR) is about 16% per year, and 19%/yr over 5 years.
Best year: 2017 (+54%). Worst year: 2018 (-5%).
It's proportional β just multiply. Over 5 years, $1,000 invested in AbbVie is worth $2,348, so $100 would be worth a tenth, $5,000 five times more, and $10,000 ten times more. Use the calculator at the top of the page for your exact amount and chosen year.
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Past performance, no predictive value and not investment advice. Prices in $, excluding dividends. Data: Yahoo Finance.